Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer
Clinical trial NCT00526799 · TERMINATED
Trial details
- NCT number
- NCT00526799
- Sponsor
- Daniela Matei, MD
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2010-01-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.